Ledger.Open graph →
SEC Form D · filed September 2, 2015

Audentes Therapeutics, Inc

Offering
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Jonathan Leff · New York, NYDirectorMatthew Patterson · San Francisco, CAExec · DirectorLouis G. Lange · San Francisco, CADirectorKush Parmar · Menlo Park, CADirectorThomas Schuetz · San Francisco, CADirectorJonathan Silverstein · New York, NYDirectorSteve Squinto · San Francisco, CADirectorThomas Woiwode · Menlo Park, CADirectorCraig Kaplan · Capitola, CAExec · DirectorRoy Carver, Jr · Fort Collins, CODirectorR. C. Pica · San Bruno, CADirectorRichard P. Fox · Rochester, NYDirectorElai R. Davicioni · San Diego, CADirectorEd Neas · Fort Collins, CODirectorDaniel R. Omstead · San Diego, CADirectorDoug C. Pica · San Bruno, CADirectorSteven Waldman · Brooklyn, NYExec · DirectorJustis G. Kao · Studio City, CADirectorBenjamin Capell · Salt Lake City, UTDirectorTomas N. Tejero · Mexico DF, O5DirectorWilliam Nelson, V · Fort Collins, CODirectorSong Yi · Metairie, LADirectorThomas Woiwode · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗